Position in ARGX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$173,492
+$136,980 QoQ
Shares Held
187
+274.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#379
of 507 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ANTIPODES PARTNERS Ltd holds $60,434,232 across 11 Biotechnology names. ARGX ranks #4 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
163,533 | $49,228,338 | |
| 2 | HUMA |
Humacyte, Inc.
|
10,103,647 | $7,880,844 | |
| 3 | GPCR |
Structure Therapeutics Inc.
|
51,262 | $2,751,231 | |
| 4 | ARGX |
Argenx SE
This page
|
187 | $173,492 | |
| 5 | IMNM |
Immunome Inc.
|
7,971 | $168,905 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
235 | $116,731 | |
| 7 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
379 | $36,944 | |
| 8 | TNGX |
Tango Therapeutics, Inc.
|
1,037 | $32,416 |
All Filings in ARGX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $173,492 | 187 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $36,512 | 50 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $164,826 | 196 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $211,679 | 287 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $183,005 | 332 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $193,539 | 327 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $71,340 | 116 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $29,272 | 54 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $33,973 | 79 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $31,103 | 79 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $30,053 | 79 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $38,838 | 79 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $22,994 | 59 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $21,982 | 59 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $37,125 | 98 | Shares | Sole | 2023-02-08 | |
| No filing history on record for this holder in this stock. | ||||||